title: ALS patients with SOD1 mutations in Switzerland show very diverse phenotypes and extremely long survival.
authors.forename: M
authors.initials: M
authors.lastname: Weber
authors.forename: C
authors.initials: C
authors.lastname: Neuwirth
authors.forename: J
authors.initials: J
authors.lastname: Thierbach
authors.forename: K
authors.initials: K
authors.lastname: Schweikert
authors.forename: A
authors.initials: A
authors.lastname: Czaplinski
authors.forename: J
authors.initials: J
authors.lastname: Petersen
authors.forename: H H
authors.initials: HH
authors.lastname: Jung
authors.forename: A
authors.initials: A
authors.lastname: Birve
authors.forename: S L
authors.initials: SL
authors.lastname: Marklund
authors.forename: P M
authors.initials: PM
authors.lastname: Andersen
mesh_terms: D000328:Adult; D000368:Aged; D000690:Amyotrophic Lateral Sclerosis / Q000235:genetics* / Q000401:mortality / Q000473:pathology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009154:Mutation / Q000235:genetics; D010641:Phenotype; D013482:Superoxide Dismutase / Q000235:genetics*; D000072105:Superoxide Dismutase-1; D013557:Switzerland / Q000453:epidemiology
chemical_list: C000606290:SOD1 protein, human; D013482:Superoxide Dismutase; D000072105:Superoxide Dismutase-1